Clinical Trials Directory

Trials / Unknown

UnknownNCT00993746

2% Lidocaine Plus 0.5% Bupivacaine Versus 0.5% Bupivacaine in Brachial Block for Creation of Arteriovenous (AV) Fistula

Comparison of Onset of Action Between 2% Lidocaine Plus 0.5% Bupivacaine and 0.5% Bupivacaine in Brachial Plexus Anesthesia for Creation of Arteriovenous Fistula in ESRD Patient

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
90 (estimated)
Sponsor
Mahidol University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Will the technique of adding lidocaine to bupivacaine fasten the onset of bupivacaine alone for infraclavicular brachial plexus block in end-stage renal disease (ESRD) patient?

Conditions

Interventions

TypeNameDescription
DRUGBupivacaine plus lidocaineBupivacaine 20 ml plus lidocaine 10 ml
DRUGBupivacaine 30 mlBupivacaine 30 ml for ultrasound guided infraclavicular brachial plexus block

Timeline

Start date
2009-10-01
Primary completion
2010-09-01
Completion
2011-09-01
First posted
2009-10-12
Last updated
2010-05-17

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT00993746. Inclusion in this directory is not an endorsement.

2% Lidocaine Plus 0.5% Bupivacaine Versus 0.5% Bupivacaine in Brachial Block for Creation of Arteriovenous (AV) Fistula (NCT00993746) · Clinical Trials Directory